Ginkgo Bioworks Holdings, Inc.·4

Nov 8, 5:18 PM ET

Kosuri Sri 4

4 · Ginkgo Bioworks Holdings, Inc. · Filed Nov 8, 2024

Insider Transaction Report

Form 4
Period: 2024-11-06
Kosuri Sri
Director
Transactions
  • Award

    Stock Option

    2024-11-06+60,24060,240 total
    Exercise: $8.31Exp: 2034-11-06Class A Common Stock (60,240 underlying)
  • Award

    Stock Option

    2024-11-06+30,91130,911 total
    Exercise: $8.31Exp: 2034-11-06Class A Common Stock (30,911 underlying)
  • Award

    Restricted Stock Units

    2024-11-06+24,06724,067 total
    Exercise: $0.00Class A Common Stock (24,067 underlying)
Footnotes (5)
  • [F1]In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the initial option award as of the grant date is $400,000.
  • [F2]The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
  • [F3]In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the additional initial option award as of the grant date is $200,000.
  • [F4]The vesting date of the RSUs and additional initial options, and in the case of the additional initial options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
  • [F5]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT